A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System
Clinical trial NCT03648372 · TERMINATED
Trial details
- NCT number
- NCT03648372
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2023-11-22
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.